Related Experiment Videos
Time to initiation of anti-tuberculosis treatment
J E Pirkis1, B R Speed, A P Yung
1National Centre for Epidemiology and Population Health, Australian National University, Victoria, Australia.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|October 1, 1996
Summary
Significant delays in tuberculosis (TB) treatment initiation were observed, with only 31% of patients starting treatment within 30 days of symptom onset. This highlights a critical gap in timely TB care.
Area of Science:
- Public Health
- Infectious Diseases
- Medical Research
Background:
- Tuberculosis (TB) remains a significant global health challenge.
- Timely initiation of treatment is crucial for effective TB management and disease control.
Purpose of the Study:
- To investigate delays in the initiation of tuberculosis treatment among patients.
- To identify specific time intervals contributing to treatment delays.
Main Methods:
- A retrospective record review of 142 notified TB patients at Fairfield Hospital, Victoria, Australia.
- Analysis focused on the time from symptom onset to treatment initiation and from sputum positivity determination to treatment initiation.
- Established 'acceptable' delay periods of 30 days and 3 days for these intervals, respectively.
Main Results:
- Only 31% of patients began treatment within the acceptable 30-day period following symptom onset.
- This delay was consistent across different TB types and patient demographics.
- For sputum smear-positive pulmonary TB, 86% received treatment within 3 days of diagnosis; delays beyond this were linked to private healthcare investigations.
Conclusions:
- Appreciable and unacceptable delays exist in initiating tuberculosis treatment.
- Strategies to address these delays are necessary to improve patient outcomes and public health.